Levine Mitchell S 4
4 · OncoCyte Corp · Filed Aug 4, 2020
Insider Transaction Report
Form 4
Levine Mitchell S
Chief Financial Officer
Transactions
- Purchase
Common Stock, no par value
2020-08-03$1.32/sh+10,000$13,200→ 36,579 total
Footnotes (1)
- [F1]2,500.000 shares purchased at $1.3165; 2,500.000 shares purchased at $1.3058; 2,500.000 shares purchased at $1.3169; and 2,500.000 shares purchased at $1.3425.